Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAew Uk Reit Regulatory News (AEWU)

Share Price Information for Aew Uk Reit (AEWU)

Share Price is delayed by 15 minutes
Get Live Data
105.60    -0.40 (-0.38%)
Bid:
105.40
Ask:
105.60
Spread: 0.20 (0.19%)
Market Cap: £167.56m
AEWU Live PriceLast checked at - London Stock Exchange

Intraday Aew Uk Reit Share Chart

Form 8.5 (EPT/RI)

1 Apr 2026 10:11

RNS Number : 0646Z
Panmure Liberum Limited
01 April 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AEW UK REIT plc

(c) Name of the party to the offer with which exempt principal trader is connected:

AEW UK REIT plc

(d) Date dealing undertaken:

31 Mar 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - Alternative Income REIT plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Sales

19,345

0.992 GBP

0.98543 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

01/04/2026

Contact name:

Rosie Kinsella

Telephone number:

+44 (0)207 886 2574

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZGGDLMLGVZG
Date   Source Headline
25th Jul 20247:00 amRNSNAV Update and Dividend Declaration
24th Jul 202412:37 pmRNSSale of multi-let industrial estate near Droitwich
2nd Jul 20247:00 amRNSAnnual Financial Report
14th Jun 20249:41 amRNSDirector Declaration
14th May 202412:27 pmRNSInvestor Presentation
14th May 20247:00 amRNSNAV Update and Dividend Declaration
26th Jan 20247:00 amRNSInvestor Presentation
25th Jan 20247:00 amRNSNAV Update and Dividend Declaration
22nd Nov 20237:00 amRNSHalf Yearly Results
23rd Oct 20239:00 amRNSClosed Period – Compliance with MAR
19th Oct 202310:26 amRNSInvestor Presentation
19th Oct 20237:00 amRNSNAV Update and Dividend Declaration
9th Oct 20237:00 amRNSSale of high-street retail asset in Portsmouth
27th Sep 20237:00 amRNSNon-material changes to Investment Policy
19th Sep 20237:00 amRNSBoard Changes
14th Sep 20234:30 pmRNSResult of AGM
8th Sep 20237:00 amRNSAcquisition of high yielding mixed-use office
1st Sep 202310:41 amRNSNotice of AGM - correction
20th Jul 20237:00 amRNSNAV Update and Dividend Declaration
19th Jul 20237:00 amRNSAcquisition of high yielding mixed use asset, York
19th Jul 20237:00 amRNSInvestor Presentation
26th Jun 20237:00 amRNSSale of two industrial assets for £16.1m
21st Jun 20237:00 amRNSAnnual Financial Report
19th Jun 20236:29 pmRNSHolding(s) in Company
9th May 20237:00 amRNSDisposal of Industrial Holding in Deeside
28th Apr 20237:00 amRNSInvestor Presentation
26th Apr 20238:10 amRNSNAV Update and Dividend Declaration
20th Apr 202312:40 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSAcquisition of high-yielding retail warehouse unit
20th Mar 20237:00 amRNSSale of Unit 1, Clarke Road, Milton Keynes
28th Feb 20233:13 pmRNSNAV Update and Dividend Declaration - Replacement
23rd Jan 20237:00 amRNSInvestor Presentation
19th Jan 20237:00 amRNSNAV Update and Dividend Declaration
1st Dec 20227:00 amRNSAcquisition of two high yielding retail assets
29th Nov 20224:25 pmRNSHolding(s) in Company
24th Nov 20225:19 pmRNSDirector Declaration
16th Nov 20227:00 amRNSHalf Yearly Results
15th Nov 20227:00 amRNSNotice of Half Year Results
10th Nov 20227:00 amRNSAppointment of Non-Executive Director
24th Oct 20224:42 pmRNSClosed Period - Compliance with MAR
24th Oct 20227:00 amRNSInvestor Presentation
20th Oct 20227:00 amRNSNAV Update and Dividend Declaration
7th Sep 20223:11 pmRNSResult of AGM
22nd Aug 20227:00 amRNSSale of 225 Bath Street, Glasgow
12th Aug 20227:00 amRNSAcquisition of high yielding Glasgow leisure asset
28th Jul 20227:00 amRNSInvestor Presentation
27th Jul 20227:00 amRNSNAV Update and Dividend Declaration
22nd Jun 20227:00 amRNSAnnual Financial Report
17th Jun 202212:20 pmRNSDirector Declaration
10th Jun 20227:00 amRNSAcquisition of Railway Station Retail Park

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.